SLN – silence therapeutics plc - american depository share (US:NASDAQ)
Stock Stats
News
Silence Therapeutics to Participate in Fireside Chat at H.C. Wainwright 2nd Annual BioConnect Investor Conference
Bitterroot Bio kickstarts Phase I trial for cardiovascular disease candidate [Yahoo! Finance]
Silence Therapeutics Announces Retirement of Alistair Gray from Board of Directors [Yahoo! Finance]
Silence Therapeutics Announces Retirement of Alistair Gray from Board of Directors
Silence Therapeutics plc (NASDAQ: SLN) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $45.00 price target on the stock.
Form DEL AM Silence Therapeutics
Form F-3 Silence Therapeutics
Form 6-K Silence Therapeutics For: May 01
Form 6-K Silence Therapeutics For: Apr 29
Form 6-K Silence Therapeutics For: Apr 15
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.